State Of Wyoming Bio N Tech Se Transaction History

State Of Wyoming

$676 Million
Q3 2024

A detailed history of State Of Wyoming transactions in Bio N Tech Se stock. As of the latest transaction made, State Of Wyoming holds 641 shares of BNTX stock, worth $72,484. This represents 0.01% of its overall portfolio holdings.

Number of Shares

641

Previous 461 39.05%

Holding current value

$72,484

Previous $37,000 105.41%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $14,104 - $22,438	180 Added 39.05%	641 $76,000
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $3,134 - $4,011	-39 Reduced 7.8%	461 $37,000
Q1 2024 May 13, 2024	BUY	$88.96 - $112.35 $44,480 - $56,175	500 New	500 $46,000
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $42,650 - $54,159	433 Added 176.73%	678 $73,000
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $25,132 - $31,766	245 New	245 $26,000
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $27,484 - $41,531	-223 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $18,811 - $34,545	149 Added 201.35%	223 $38,000
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $3,249 - $5,437	15 Added 25.42%	74 $19,000
Q3 2021 Feb 11, 2022	BUY	$205.93 - $447.23 $4,118 - $8,944	20 Added 51.28%	59 $16,000
Q2 2021 Feb 11, 2022	SELL	$113.32 - $241.49 $3,626 - $7,727	-32 Reduced 45.07%	39 $9,000
Q1 2021 Feb 08, 2022	BUY	$85.73 - $119.5 $6,086 - $8,484	71 New	71 $8,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account